- Home
- NDRA vs FRSX Comparison
NDRA vs FRSX Comparison
Compare NDRA & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- FRSX
- Stock Information
- Founded
- NDRA 2007
- FRSX N/A
- Country
- NDRA United States
- FRSX Israel
- Employees
- NDRA N/A
- FRSX N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- FRSX Computer Software: Prepackaged Software
- Sector
- NDRA Health Care
- FRSX Technology
- Exchange
- NDRA Nasdaq
- FRSX Nasdaq
- Market Cap
- NDRA 7.3M
- FRSX 7.7M
- IPO Year
- NDRA 2017
- FRSX 2017
- Fundamental
- Price
- NDRA $4.53
- FRSX $2.12
- Analyst Decision
- NDRA Strong Buy
- FRSX
- Analyst Count
- NDRA 1
- FRSX 0
- Target Price
- NDRA $38.00
- FRSX N/A
- AVG Volume (30 Days)
- NDRA 45.9K
- FRSX 17.2K
- Earning Date
- NDRA 11-17-2025
- FRSX 11-13-2025
- Dividend Yield
- NDRA N/A
- FRSX N/A
- EPS Growth
- NDRA N/A
- FRSX N/A
- EPS
- NDRA N/A
- FRSX N/A
- Revenue
- NDRA N/A
- FRSX $452,000.00
- Revenue This Year
- NDRA N/A
- FRSX N/A
- Revenue Next Year
- NDRA N/A
- FRSX N/A
- P/E Ratio
- NDRA N/A
- FRSX N/A
- Revenue Growth
- NDRA N/A
- FRSX N/A
- 52 Week Low
- NDRA $2.90
- FRSX $1.98
- 52 Week High
- NDRA $11.96
- FRSX $18.41
- Technical
- Relative Strength Index (RSI)
- NDRA 42.26
- FRSX 46.77
- Support Level
- NDRA $6.06
- FRSX $1.99
- Resistance Level
- NDRA $6.80
- FRSX $2.26
- Average True Range (ATR)
- NDRA 0.84
- FRSX 0.12
- MACD
- NDRA -0.12
- FRSX -0.02
- Stochastic Oscillator
- NDRA 23.44
- FRSX 37.96
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.